TherapeuticsMD (TXMD) Other Non Operating Income (2011 - 2023)
TherapeuticsMD's (TXMD) quarterly Other Non Operating Income came in at $359000.0 in Q3 2023, up 420.54% YoY from $68967.4 in Q3 2022, and up 248.54% on a QoQ basis from $103000.0 in Q2 2023.
TherapeuticsMD (TXMD) Other Non Operating Income (2011 - 2023) Analysis & Trends
TherapeuticsMD (TXMD) has 12 years of Other Non Operating Income data on file, last reported at $359000.0 in Q3 2023.
- Quarterly Other Non Operating Income rose 420.54% year-over-year to $359000.0 in Q3 2023, while the trailing twelve-month figure through Sep 2023 was $880000.0 (up 110.33% YoY) and the FY2022 annual result came in at -$117000.0, down 143.01% from the prior year.
- Other Non Operating Income improved to $359000.0 in Q3 2023, from $103000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $703662.0 in Q3 2019 to a low of -$11.9 million in Q4 2019.
- A 5-year average of -$1.4 million and a median of $89000.0 in 2020 frame the typical range for Other Non Operating Income.
- Annual changes were most pronounced in 2022 — Other Non Operating Income slumped 6985.25% — and 2023, when it jumped 743.75%.
- Tracing TXMD's Other Non Operating Income over 5 years: stood at -$11.9 million in 2019, then soared by 101.11% to $132000.0 in 2020, then plunged by 93.94% to $8000.0 in 2021, then jumped by 37.5% to $11000.0 in 2022, then surged by 3163.64% to $359000.0 in 2023.
- The last three Other Non Operating Income figures came in at $359000.0 (Q3 2023), $103000.0 (Q2 2023), and $407000.0 (Q1 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | TherapeuticsMD | 23.56 Mn | 14.37 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 359,000.00 |
| Jun 30, 2023 | 103,000.00 |
| Mar 31, 2023 | 407,000.00 |
| Dec 31, 2022 | 11,000.00 |
| Sep 30, 2022 | -112,000.00 |
| Jun 30, 2022 | -16,000.00 |
| Mar 31, 2022 | -8.40 Mn |
| Dec 31, 2021 | 8,000.00 |
| Sep 30, 2021 | 19,000.00 |
| Jun 30, 2021 | 123,000.00 |
| Mar 31, 2021 | 122,000.00 |
| Dec 31, 2020 | 132,000.00 |
| Sep 30, 2020 | 42,000.00 |
| Jun 30, 2020 | 89,000.00 |
| Mar 31, 2020 | 335,000.00 |
| Dec 31, 2019 | -11.94 Mn |
| Sep 30, 2019 | 703,662.00 |
| Jun 30, 2019 | -10.10 Mn |
| Mar 31, 2019 | 688,721.00 |
| Dec 31, 2018 | 823,027.00 |